-
Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
… to volunteer for additional MRI measurements. Impact on Diagnosis/Treatment of Parkinson’s Disease: … waste and eliminating free radicals. Three decades of research suggests that individuals with PD have reduced … in a measurable symptomatic effect over placebo, future research efforts should focus on the capacity of (in)GSH to …
-
Optimization of Probe-ELISA Parkin Activity Assay
… people with and without Parkinson's. Importance of This Research for the Development of a New PD Therapy: Our … Research Grant …
-
Structure-Based Design of Small-Molecule Activators of Parkin
… their ability to increase its activity. Importance of This Research for the Development of a New PD Therapy: Loss of … Research Grant …
-
Data Driven Subtyping of Parkinson's Disease Patients in the BioFIND Study
… Progression Markers Initiative (PPMI). Impact on Diagnosis/Treatment of Parkinson's disease: Identifying … understand the variability of the disease. This can help researchers and clinicians develop better therapeutics and … Research Grant …
-
Radioactive Molecules for Detection of Alpha-synuclein and Amyloid-beta in the Brain
… and beta-amyloid tracers -- molecules that allow researchers and clinicians to detect these two proteins in … a follow-up phone interview several days later. Impact on Diagnosis/Treatment of Parkinson's disease: Radioactive … Research Grant …
-
Developing TLR2-Blocking Drugs to Reduce Alpha-synuclein-Induced Inflammation in Parkinson's Disease
… process for production of these drugs. Importance of This Research for the Development of a New PD Therapy: Blocking … Research Grant …